ViAn Therapeutics
October 16, 2023
Franciscan C
Ophthalmology
ViAn Therapeutics is a visionary virtual pharma startup at the forefront of combating microvascular retinal diseases. Focused on conditions like diabetic retinopathy and age-related macular degeneration, we're pioneering a novel solution: ViAn-c4551, a groundbreaking cyclic peptide drug delivered via convenient eyedrop administration. By swiftly stabilizing retinal blood vessels, our non-invasive approach aims to halt vision deterioration earlier than traditional methods (e.g., intraocular injections). With millions affected, ViAn Therapeutics aims to redefine ocular care, offering hope for clearer sight and a brighter future of retinal health.
Speaker(s)
Juan Pablo Robles
Headquarters Location
San Francisco, California
Innovation Supporter
UCSF & IndieBio
Website
https://www.linkedin.com/company/vian-tx/